Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Dawson

Showing results (51-60 of 405) with videos related to

Pageof 41
Sort By:
Trends in Pharmacological Sciences|May 15, 2012
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's diseaseByoung Dae Lee, Valina L Dawson, Ted M Dawson
Methods in Enzymology|November 18, 2005
Identification and evaluation of NO-regulated genes by differential analysis of primary cDNA library expression (DAzLE)Suk J Hong, Valina L Dawson, Ted M Dawson
Cell|October 20, 2009
SnapShot: pathogenesis of Parkinson's diseaseJoo-Ho Shin, Valina L Dawson, Ted M Dawson
The Journal of Clinical Investigation|July 11, 2006
Diagnosis and treatment of Parkinson disease: molecules to medicineJoseph M Savitt, Valina L Dawson, Ted M Dawson
Trends in Pharmacological Sciences|May 4, 2004
Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signalingSuk Jin Hong, Ted M Dawson, Valina L Dawson
Neuromolecular Medicine|October 7, 2003
Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidosesDarren J Moore, Valina L Dawson, Ted M Dawson
Nature Medicine|February 8, 2012
Ironing out tau's role in parkinsonismJeannette N Stankowski, Valina L Dawson, Ted M Dawson
Frontiers in Neurology|May 24, 2021
Targeting Parthanatos in Ischemic StrokeRaymond C Koehler, Valina L Dawson, Ted M Dawson
Cell Cycle (Georgetown, Tex.)|February 24, 2005
The road to survival goes through PARGDavid W Koh, Valina L Dawson, Ted M Dawson
Pharmacological Research|May 25, 2005
Mediation of cell death by poly(ADP-ribose) polymerase-1David W Koh, Ted M Dawson, Valina L Dawson
Pageof 41

Showing results (51-60 of 405) with videos related to

Sort By:
Pageof 41
Trends in Pharmacological Sciences|May 15, 2012
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's diseaseByoung Dae Lee, Valina L Dawson, Ted M Dawson
Methods in Enzymology|November 18, 2005
Identification and evaluation of NO-regulated genes by differential analysis of primary cDNA library expression (DAzLE)Suk J Hong, Valina L Dawson, Ted M Dawson
Cell|October 20, 2009
SnapShot: pathogenesis of Parkinson's diseaseJoo-Ho Shin, Valina L Dawson, Ted M Dawson
The Journal of Clinical Investigation|July 11, 2006
Diagnosis and treatment of Parkinson disease: molecules to medicineJoseph M Savitt, Valina L Dawson, Ted M Dawson
Trends in Pharmacological Sciences|May 4, 2004
Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signalingSuk Jin Hong, Ted M Dawson, Valina L Dawson
Neuromolecular Medicine|October 7, 2003
Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidosesDarren J Moore, Valina L Dawson, Ted M Dawson
Nature Medicine|February 8, 2012
Ironing out tau's role in parkinsonismJeannette N Stankowski, Valina L Dawson, Ted M Dawson
Frontiers in Neurology|May 24, 2021
Targeting Parthanatos in Ischemic StrokeRaymond C Koehler, Valina L Dawson, Ted M Dawson
Cell Cycle (Georgetown, Tex.)|February 24, 2005
The road to survival goes through PARGDavid W Koh, Valina L Dawson, Ted M Dawson
Pharmacological Research|May 25, 2005
Mediation of cell death by poly(ADP-ribose) polymerase-1David W Koh, Ted M Dawson, Valina L Dawson
Pageof 41